Labcorp Holdings Other Income (Expense) increased by 32.5% to -$13.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1210.0%, from -$1.00M to -$13.10M. Over 2 years (FY 2023 to FY 2025), Other Income (Expense) shows a downward trend with a 88.4% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.10M | $31.90M | -$10.10M | -$29.50M | -$17.60M | -$6.90M | -$16.90M | $21.10M | $18.20M | $20.00M | $19.50M | $4.30M | $16.40M | -$1.00M | -$32.70M | -$1.90M | -$19.40M | -$13.10M |
| QoQ Change | — | +126.2% | -131.7% | -192.1% | +40.3% | +60.8% | -144.9% | +224.9% | -13.7% | +9.9% | -2.5% | -77.9% | +281.4% | -106.1% | <-999% | +94.2% | -921.1% | +32.5% |
| YoY Change | — | — | — | -309.2% | -155.2% | +31.7% | +42.7% | +219.9% | — | +389.9% | +215.4% | -79.6% | -9.9% | -105.0% | -267.7% | -144.2% | -218.3% | <-999% |